A Senate vote failed to halt the WISeR AI-based prior authorization pilot for traditional Medicare claims.
Key Details
- 1Senate Democrats attempted to use the Congressional Review Act to stop the CMS WISeR program but lost 46-50.
- 2WISeR uses AI to automate the approval and denial of traditional Medicare claims in six states.
- 3The pilot involves multiple private vendors: Cohere Health, Genzeon Corporation, Humata Health, Innovaccer, Virtix Health, and Zyter.
- 4Opponents cite risks of care delays and denials for seniors due to AI-driven prior authorizations.
- 5Supporters argue the pilot could reduce waste and fraud in Medicare.
Why It Matters
AI-driven prior authorization has major implications for radiology reimbursement, patient access, and care delays. This marks a pivotal test of AI’s regulatory and economic impact on healthcare workflows, particularly for imaging services.
Source
HealthExec
Related News
•AuntMinnie
HPI Rebuts AI's Supposed Impact on Radiology Workforce Shortage
Harvey L. Neiman HPI challenges recent claims that AI has lessened the radiology workforce burden, citing evidence of rising workloads and imaging volumes.
•Radiology Business
Everlywell Launches Direct-to-Consumer Mammography AI for Breast Cancer Risk
Everlywell now offers the FDA-authorized Clairity Breast AI tool for patients to assess breast cancer risk from their mammograms.
•Radiology Business
Rad Partners Wins $1.29M FDA Grant for AI Radiology Report Evaluation Study
Cognita Imaging, part of Rad Partners, has received a $1.29M FDA grant to develop a new framework using large language models (LLMs) to evaluate AI-generated radiology reports.